Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.
about
Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targetsMesenchymal stem cells and immunomodulation: current status and future prospectsThe Long Path of Human Placenta, and Its Derivatives, in Regenerative MedicineEx vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.Human placenta-derived adherent cells induce tolerogenic immune responsesHuman placenta-derived adherent cells improve cardiac performance in mice with chronic heart failure.Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental CellsHuman placenta-derived adherent cell treatment of experimental stroke promotes functional recovery after stroke in young adult and older rats.Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review.Concise Review: Cellular Therapies: The Potential to Regenerate and Restore Tolerance in Immune-Mediated Intestinal Diseases.Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical Trial.Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.Can Umbilical Cord Mesenchymal Stem Cells Treatment Be a Hope for Patients with Refractory Crohn's Disease?
P2860
Q26752806-34E1BB10-174D-47B6-85CA-B62A6788834BQ26770191-4484FA7D-D87E-4BB3-BEA8-7F371A375A3BQ26779265-F81AC214-7F1F-44F5-AB35-286F55B2B40DQ30660529-2758DABE-5420-40CE-A7BD-A6B29FF97FB1Q34511652-5B5DC5F5-B75A-482A-8A0B-15AEE12F333EQ35119685-BEE7BF7B-A167-42F6-A314-C13323F79E9BQ36067842-D66FEEA6-35FF-455B-B410-ECE953685D11Q37500528-9FA67470-FE99-4C06-A60D-85D90BDACD75Q38393820-2ABF4534-435F-4AC0-8942-6D1E04361564Q38789482-8D51A58E-CA13-482C-8CA0-451EDA7601EDQ40040646-44060E85-55CA-427A-8598-BFB2BBE65323Q45013680-174E93F7-050F-4625-881E-D4965102DDDFQ47561955-59D44F00-AF09-43EA-B179-FCD79A8D0976
P2860
Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety and tolerability of hum ...... hn's disease: a phase 1 study.
@ast
Safety and tolerability of hum ...... hn's disease: a phase 1 study.
@en
Safety and tolerability of human placenta-derived cells
@nl
type
label
Safety and tolerability of hum ...... hn's disease: a phase 1 study.
@ast
Safety and tolerability of hum ...... hn's disease: a phase 1 study.
@en
Safety and tolerability of human placenta-derived cells
@nl
prefLabel
Safety and tolerability of hum ...... hn's disease: a phase 1 study.
@ast
Safety and tolerability of hum ...... hn's disease: a phase 1 study.
@en
Safety and tolerability of human placenta-derived cells
@nl
P2093
P2860
P1476
Safety and tolerability of hum ...... hn's disease: a phase 1 study.
@en
P2093
Denise Payne
Gil Y Melmed
Herbert Faleck
Kristine Johnson
Lloyd Mayer
Robert J Hariri
Stephen B Hanauer
Steven A Fischkoff
William M Pandak
P2860
P304
P356
10.1097/MIB.0B013E31827F27DF
P577
2013-03-01T00:00:00Z